Page 259 - Remedial Andrology

1810. Bouloux, P., et al. Efficacy and safety of recombinant human follicle-stimulating hormone in men
with isolated hypogonadotropic hypogonadism. Fertil Steril, 2002. 77: 270.
https://pubmed.ncbi.nlm.nih.gov/11821082
1811. Jones, T.H., et al. Self-administered subcutaneous human menopausal gonadotrophin for the
stimulation of testicular growth and the initiation of spermatogenesis in hypogonadotrophic
hypogonadism. Clin Endocrinol (Oxf), 1993. 38: 203.
https://pubmed.ncbi.nlm.nih.gov/8435901
1812. Burris, A.S., et al. Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the
response to human chorionic gonadotropin is predicted by initial testicular size. J Clin Endocrinol
Metab, 1988. 66: 1144.
https://pubmed.ncbi.nlm.nih.gov/3372679
1813. Dwyer, A.A., et al. Trial of recombinant follicle-stimulating hormone pretreatment for GnRH-induced
fertility in patients with congenital hypogonadotropic hypogonadism. J Clin Endocrinol Metab, 2013.
98: E1790.
https://pubmed.ncbi.nlm.nih.gov/24037890
1814. Liu, P.Y., et al. Induction of spermatogenesis and fertility during gonadotropin treatment of
gonadotropin-deficient infertile men: predictors of fertility outcome. J Clin Endocrinol Metab, 2009.
94: 801.
https://pubmed.ncbi.nlm.nih.gov/19066302
1815. Ribeiro, R.S., et al. Clomiphene fails to revert hypogonadism in most male patients with conventionally
treated nonfunctioning pituitary adenomas. Arq Bras Endocrinol Metabol, 2011. 55: 266.
https://pubmed.ncbi.nlm.nih.gov/21779629
1816. Simoni, M., et al. Prospects for FSH Treatment of Male Infertility. J Clin Endocrinol Metab, 2020.
105.
https://pubmed.ncbi.nlm.nih.gov/32374828
1817. Colacurci, N., et al. Recombinant FSH improves sperm DNA damage in male infertility: A phase II
clinical trial. Frontiers in Endocrinology, 2018. 9: 383.
https://pubmed.ncbi.nlm.nih.gov/30042737
1818. Ding, Y.M., et al. Treatment of idiopathic oligozoospermia with recombinant human follicle-
stimulating hormone: A prospective, randomized, double-blind, placebo-controlled clinical study in
Chinese population. Clinical Endocrinology, 2015. 83: 866.
https://pubmed.ncbi.nlm.nih.gov/25761129
1819. Shinjo, E., et al. The effect of human chorionic gonadotropin-based hormonal therapy on
intratesticular testosterone levels and spermatogonial DNA synthesis in men with non-obstructive
azoospermia. Andrology, 2013. 1: 929.
https://pubmed.ncbi.nlm.nih.gov/24123916
1820. Simoni, M., et al. Treatment with human, recombinant FSH improves sperm DNA fragmentation in
idiopathic infertile men depending on the FSH receptor polymorphism p.N680S: A pharmacogenetic
study. Human Reprod, 2016. 31: 1960.
https://pubmed.ncbi.nlm.nih.gov/27329968
1821. Cannarella, R., et al. FSH dosage effect on conventional sperm parameters: a meta-analysis of
randomized controlled studies. Asian J Androl, 2020. 22: 309.
https://pubmed.ncbi.nlm.nih.gov/31274479
1822. Attia, A.M., et al. Gonadotrophins for idiopathic male factor subfertility. The Cochrane database of
systematic reviews, 2013. 8: CD005071.
https://pubmed.ncbi.nlm.nih.gov/23970458
1823. Santi, D., et al. FSH treatment of male idiopathic infertility improves pregnancy rate: A meta-
analysis. Endocrine Connections, 2015. 4: R46.
https://pubmed.ncbi.nlm.nih.gov/26113521
1824. Cocci, A., et al. Effectiveness of highly purified urofollitropin treatment in patients with idiopathic
azoospermia before testicular sperm extraction. Urologia J, 2018. 85: 19.
https://pubmed.ncbi.nlm.nih.gov/28799634
1825. Hussein, A., et al. Optimization of spermatogenesis-regulating hormones in patients with non-
obstructive azoospermia and its impact on sperm retrieval: A multicentre study. BJU Int, 2013.
111: E110.
https://pubmed.ncbi.nlm.nih.gov/22958644
1826. Gul, U., et al. The effect of human chorionic gonadotropin treatment before testicular sperm
extraction in non-obstructive azoospermia. J Clin Analyt Med, 2016. 7: 55.
http://acikerisim.baskent.edu.tr:8080/xmlui/bitstream/handle/11727/3891/JCAM-3332.
pdf?sequence=1&isAllowed=y

258 SEXUAL AND REPRODUCTIVE HEALTH - MARCH 2021